Rights and permissions
About this article
Cite this article
Tocilizumab expected to find favour with US rheumatologists. Inpharma Wkly. 1651, 4 (2008). https://doi.org/10.2165/00128413-200816510-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200816510-00006